Cite
HARVARD Citation
Manos, K. et al. (2021). Safe administration of obinutuzumab to rituximab-intolerant patients. Leukemia & lymphoma. 62 (14), pp. 3552-3554. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Manos, K. et al. (2021). Safe administration of obinutuzumab to rituximab-intolerant patients. Leukemia & lymphoma. 62 (14), pp. 3552-3554. [Online].